These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24971583)

  • 21. Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.
    Martayan A; Fraioli R; Giorda E; Setini A; Ciccarelli G; Delfino L; Ferrara GB; Giacomini P
    Br J Cancer; 1999 May; 80(5-6):639-49. PubMed ID: 10360639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
    Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
    Wang Z; Arienti F; Parmiani G; Ferrone S
    Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
    McEvoy CR; Seshadri R; Morley AA; Firgaira FA
    Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of class I human leukocyte antigen (HLA) and beta2-microglobulin is associated with decidualization of human endometrial stromal cells.
    Komatsu T; Konishi I; Mandai M; Mori T; Hiai H; Fukumoto M
    Hum Reprod; 1998 Aug; 13(8):2246-51. PubMed ID: 9756305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
    Chawla A; Alatrash G; Philips AV; Qiao N; Sukhumalchandra P; Kerros C; Diaconu I; Gall V; Neal S; Peters HL; Clise-Dwyer K; Molldrem JJ; Mittendorf EA
    Cancer Immunol Immunother; 2016 Jun; 65(6):741-51. PubMed ID: 27129972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
    Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
    J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of HLA-E expression in human tumors.
    Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
    Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.
    Hasegawa K; Tagawa M; Takagi K; Tsukamoto H; Tomioka Y; Suzuki T; Nishioka Y; Ohrui T; Numasaki M
    Cancer Gene Ther; 2016 Aug; 23(8):266-77. PubMed ID: 27561689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
    Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
    J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines.
    Lei WY; Hsiung SC; Wen SH; Hsieh CH; Chen CL; Wallace CG; Chang CC; Liao SK
    J Immunol Res; 2018; 2018():8363265. PubMed ID: 30648121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
    Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
    Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
    de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
    J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
    de Vrij J; Uil TG; van den Hengel SK; Cramer SJ; Koppers-Lalic D; Verweij MC; Wiertz EJ; Vellinga J; Willemsen RA; Hoeben RC
    Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines.
    Shields MJ; Kubota R; Hodgson W; Jacobson S; Biddison WE; Ribaudo RK
    J Biol Chem; 1998 Oct; 273(43):28010-8. PubMed ID: 9774416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.
    Roemer MG; Advani RH; Redd RA; Pinkus GS; Natkunam Y; Ligon AH; Connelly CF; Pak CJ; Carey CD; Daadi SE; Chapuy B; de Jong D; Hoppe RT; Neuberg DS; Shipp MA; Rodig SJ
    Cancer Immunol Res; 2016 Nov; 4(11):910-916. PubMed ID: 27737878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
    Peters HL; Tripathi SC; Kerros C; Katayama H; Garber HR; St John LS; Federico L; Meraz IM; Roth JA; Sepesi B; Majidi M; Ruisaard K; Clise-Dwyer K; Roszik J; Gibbons DL; Heymach JV; Swisher SG; Bernatchez C; Alatrash G; Hanash S; Molldrem JJ
    Cancer Immunol Res; 2017 Apr; 5(4):319-329. PubMed ID: 28254787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
    Hicklin DJ; Dellaratta DV; Kishore R; Liang B; Kageshita T; Ferrone S
    Melanoma Res; 1997 Aug; 7 Suppl 2():S67-74. PubMed ID: 9578419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.